Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

CD44 variant changes start alopecia areata, but don't maintain it.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Hair follicles help skin immune recovery after UVB exposure.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

The skin's immune system helps it regenerate and fight infections.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Enterococcus faecalis delays wound healing by disrupting cell functions and creating an anti-inflammatory environment.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Innate lymphoid cells help us understand and manage allergic diseases better.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.